Temporal trends in bleeding events in acute myocardial infarction: insights from the SWEDEHEART registry. (1st September 2019)

• Record Type: Journal Article
• Authors: Simonsson, Moa; Wallentin, Lars; Alfredsson, Joakim; Erlinge, David; Hellström Ängerud, Karin; Hofmann, Robin; Kellerth, Thomas; Lindhagen, Lars; Ravn-Fischer, Annica; Szummer, Karolina; Ueda, Peter; Yndigegn, Troels; Jernberg, Tomas
• Is Part Of: European heart journal. Volume 41:Number 7(2020)
• Page Start: 833
• Page End: 843
• Publication Date: 2019-09-01
• Subjects: Bleeding -- Acute myocardial infarction -- Registry -- Temporal trends; Cardiology -- Periodicals; Heart -- Diseases -- Periodicals; 616.12005
• DOI: 10.1093/eurheartj/ehz593
• Languages: English
• ISSNs: 0195-668X

Abstract

Abstract: Aims: To describe the time trends of in-hospital and out-of-hospital bleeding parallel to the development of new treatments and ischaemic outcomes over the last 20 years in a nationwide myocardial infarction (MI) population. Methods and results: Patients with acute MI ( n = 371 431) enrolled in the SWEDEHEART registry from 1995 until May 2018 were selected and evaluated for in-hospital bleeding and out-of-hospital bleeding events at 1 year. In-hospital bleeding increased from 0.5% to a peak at 2% 2005/2006 and thereafter slightly decreased to a new plateau around 1.3% by the end of the study period. Out-of-hospital bleeding increased in a stepwise fashion from 2.5% to 3.5 % in the middle of the study period and to 4.8% at the end of the study period. The increase in both in-hospital and out-of-hospital bleeding was parallel to increasing use of invasive strategy and adjunctive antithrombotic treatment, dual antiplatelet therapy (DAPT), and potent DAPT, while the decrease in in-hospital bleeding from 2007 to 2010 was parallel to implementation of bleeding avoidance strategies. In-hospital re-infarction decreased from 2.8% to 0.6% and out-of-hospital MI decreased from 12.6% to 7.1%. The composite out-of-hospital MI, cardiovascular death, and stroke decreased in a similar fashion from 18.4% to 9.1%. Conclusion: During the last 20 years, the introduction of invasive and more intense antithrombotic treatment has been associated with an increase in bleeding events but concomitant there has been a substantial greater reduction of ischaemic events including improved survival.